NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,388,901 | +2.9% | 347,427 | +1.9% | 0.06% | +4.9% |
| Q2 2023 | $34,402,974 | +12.7% | 340,927 | +2.7% | 0.06% | +5.2% |
| Q1 2023 | $30,531,771 | -5.5% | 331,867 | -6.8% | 0.06% | -10.8% |
| Q4 2022 | $32,305,974 | +9.4% | 356,113 | -8.4% | 0.06% | -1.5% |
| Q3 2022 | $29,540,000 | -8.3% | 388,639 | +1.9% | 0.07% | -5.7% |
| Q2 2022 | $32,226,000 | -0.9% | 381,245 | +2.9% | 0.07% | +14.8% |
| Q1 2022 | $32,522,000 | +23.8% | 370,630 | +23.4% | 0.06% | +24.5% |
| Q4 2021 | $26,268,000 | +9.4% | 300,305 | +2.3% | 0.05% | 0.0% |
| Q3 2021 | $24,000,000 | -3.9% | 293,473 | +7.2% | 0.05% | -3.9% |
| Q2 2021 | $24,985,000 | +13.5% | 273,838 | +6.4% | 0.05% | +2.0% |
| Q1 2021 | $22,007,000 | -3.7% | 257,453 | +6.4% | 0.05% | -12.3% |
| Q4 2020 | $22,849,000 | +7.8% | 241,974 | -0.7% | 0.06% | -5.0% |
| Q3 2020 | $21,197,000 | +4.0% | 243,759 | +4.5% | 0.06% | -7.7% |
| Q2 2020 | $20,382,000 | +5.1% | 233,373 | -0.8% | 0.06% | -23.5% |
| Q1 2020 | $19,401,000 | -0.3% | 235,323 | +14.5% | 0.08% | +37.1% |
| Q4 2019 | $19,456,000 | +22.8% | 205,474 | +12.7% | 0.06% | +6.9% |
| Q3 2019 | $15,850,000 | -8.8% | 182,395 | -4.2% | 0.06% | -13.4% |
| Q2 2019 | $17,388,000 | +5.6% | 190,430 | +11.2% | 0.07% | -1.5% |
| Q1 2019 | $16,463,000 | +39.0% | 171,246 | +24.1% | 0.07% | +9.7% |
| Q4 2018 | $11,843,000 | +5.9% | 138,005 | +6.4% | 0.06% | +21.6% |
| Q3 2018 | $11,181,000 | +15.0% | 129,760 | +0.9% | 0.05% | +4.1% |
| Q2 2018 | $9,719,000 | -6.2% | 128,653 | +0.4% | 0.05% | -18.3% |
| Q1 2018 | $10,364,000 | +7.0% | 128,183 | +11.1% | 0.06% | -1.6% |
| Q4 2017 | $9,690,000 | -3.5% | 115,405 | -1.3% | 0.06% | -4.7% |
| Q3 2017 | $10,040,000 | +2.9% | 116,946 | +0.0% | 0.06% | -4.5% |
| Q2 2017 | $9,760,000 | +42.3% | 116,921 | +26.6% | 0.07% | +28.8% |
| Q1 2017 | $6,857,000 | +42.1% | 92,325 | +39.4% | 0.05% | +26.8% |
| Q4 2016 | $4,825,000 | -6.6% | 66,242 | +1.2% | 0.04% | -10.9% |
| Q3 2016 | $5,168,000 | -5.6% | 65,443 | -1.4% | 0.05% | -13.2% |
| Q2 2016 | $5,476,000 | +24.7% | 66,368 | +9.5% | 0.05% | +3.9% |
| Q1 2016 | $4,391,000 | -6.5% | 60,616 | +11.0% | 0.05% | -7.3% |
| Q4 2015 | $4,697,000 | -3.2% | 54,589 | +3.4% | 0.06% | -32.1% |
| Q3 2015 | $4,851,000 | +174.5% | 52,772 | +111.2% | 0.08% | +55.8% |
| Q2 2013 | $1,767,000 | – | 24,984 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |